Rheumera vs Actuvi
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Rheumera
This app facilitates better communication between rheumatology patients and their healthcare providers. It enables consistent sharing of health information to improve treatment accuracy and responsiveness. Join a community dedicated to collaborative care.
- Patient-provider information sharing
- Feedback and review cadence
- Identify treatment effectiveness
- Respond to changing needs
- Collaborative care community
Read full descriptionHide full description
Our app empowers patients and providers to dramatically improve the frequency, accuracy, and quality of the information they share. By creating a robust and ongoing cadence of feedback and review, physicians and patients are able to quickly identify and respond to what’s working and what needs to change. Our team of Rheumatologists, Patients, Clinical Staff, and Technologist came together through a common belief - we are better together. Consider this our invitation to join us. We can’t wait to meet YOU.
Actuvi
This app facilitates remote healthcare by connecting patients with their doctors. It offers features like patient monitoring, direct messaging with care teams, and telehealth appointments.
- Patient monitoring
- Direct messaging with care team
- Telehealth appointments
- Digital care delivery
Read full descriptionHide full description
Delivering digital care between patients and doctors. Patient Monitoring, direct messaging between patient and care team, telehealth and more.
Screenshots
Verdict
The clearest difference is review sentiment: Rheumera at 57% against Actuvi's 25%. Rheumera also leads on rating (3.9 vs 3.5) and ratings volume (122 vs 21). On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Rheumera holds the better App Store score, 3.9 against 3.5. That said, the two scores are not equally well evidenced: Rheumera has 122 ratings behind it against 21, so its average is the more settled of the two. Written reviews point the same way: 57% of Rheumera's written reviews are positive against 25% of Actuvi's.
Rheumera ships an update every 4 weeks, Actuvi fortnightly. The most recent releases landed on November 8, 2026 and November 4, 2026 respectively.
| Parameter | Rheumera | Actuvi |
|---|---|---|
| Price | Free | Free |
| Rating | 3.9 (122 ratings) — better | 3.5 (21 ratings) |
| Positive reviews | 56.7% of reviews — better | 25.0% of reviews |
| Number of ratings | 122 — better | 21 |
| Update frequency | Every 4 weeks | Fortnightly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPod | iPhone, iPad |
| Requires iOS | 15.6 — better | 16.4 |
| Further details — not scored | ||
| Size | 93 MB | 173 MB |
| Age rating | 17+ | 17+ |
| Developer | Rheumera Inc | Actuvi, LLC |
Customer experience
Rheumera
Actuvi
In-app purchases
Rheumera
No in-app purchases
Actuvi
No in-app purchases
